Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis
Phase 1
Active, not recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Genetic: ICM-203Drug: Placebo
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- ICM Biotech Australia Pty Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT04875754
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺Barwon Health, Geelong, Victoria, Australia
News
No news found